Oct 10, 2019
Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
Oct 04, 2019
Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years
Aug 21, 2019
U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer
Aug 14, 2019
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019
Aug 06, 2019
Global Acne (Medication and Therapeutic Devices) Treatment Market 2019-2023 - Key Players are Foamix Pharmaceuticals, Bausch Health Companies, Nestle and Allergan
Jun 19, 2019
Global Acne Market Spotlight 2017-2018 & 2019-2026 - ResearchAndMarkets.com
May 23, 2019
European Union Benzoyl Peroxide and Benzoyl Chloride Markets, 2013-2017 & 2018-2023 - ResearchAndMarkets.com
May 22, 2019
BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea
Mar 28, 2019
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
Mar 04, 2019
BioPharmX Completes Enrollment in Phase 2b Trial of BPX-04 for Patients with Papulopustular Rosacea
Feb 28, 2019
Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology
Jan 17, 2019
Novel Oral Antibiotic Treatment Seysara(TM) (sarecycline) Now Available
Nov 15, 2018
Acne Drugs Market Size Worth $5.9 Billion By 2025 | CAGR: 4.2%: Grand View Research, Inc.
Nov 05, 2018
Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula
Oct 11, 2018
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea
Oct 11, 2018
Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months
Oct 11, 2018
Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO(TM) (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology
Sep 17, 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Jul 27, 2018
Acne Medication Market Expected to Reach $10,929 Million by 2025 | CAGR 3.9% - Allied Market Research
Jul 19, 2018
BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01